Teva API

Active Pharmaceutical Ingredients (API) Manufacturingteva-api.com

TAPI is the API manufacturing and CDMO arm of Teva Pharmaceutical Industries, supplying 350+ active pharmaceutical ingredients and custom development services across peptides, oligonucleotides, small molecules, and biosynthetic modalities to global pharmaceutical manufacturers. Founded in 1935 with 1,001–5,000 employees.

Company typePrivate
Founded1935
HeadquartersWoodcliff Lake, United States
Headcount1,001–5,000
GTM typeB2B
OfferingHardware or Manufacturing

What Teva API does

TAPI (legal entity Assia Chemical Industries Ltd), the API manufacturing and CDMO arm of Teva Pharmaceutical Industries, manufactures and supplies over 350 active pharmaceutical ingredients and offers custom development and manufacturing services across multiple modalities including small molecules, peptides, oligonucleotides, fermentation products, steroids, and high potents/ADC. Founded in 1935 and headquartered in Woodcliff Lake, NJ with the legal entity domiciled in Israel, the company employs between 1,001 and 5,000 people and operates as the leading international supplier of APIs to generic drug manufacturers globally.

The company's technology base spans 85+ years of manufacturing expertise, supported by DoE-driven process optimization, PAT-enabled quality control, and specialized containment for high-potency compounds. Core offerings include the API Catalog (350+ off-the-shelf generic APIs), CDMO Services (custom development from concept to commercial scale), and a dedicated peptides and oligonucleotides practice with GLP-1 manufacturing capability. The TAPI Connect self-service portal provides customers 24/7 access to documentation, order tracking, and regulatory updates. Recent strategic moves include a biosynthetic ingredient partnership with Antheia (November 2025) and a global licensing agreement with Sagimet Biosciences for Resmetirom API (December 2025).

TAPI generates revenue through three streams: API product sales, CDMO services under multi-year contracts with development and manufacturing fees, and licensing/royalty arrangements. Pricing is quote-based and not publicly disclosed. The company sells primarily to pharmaceutical manufacturers through direct enterprise field sales, the TAPI Connect self-service portal, and presence at major industry events including CPHI, TIDES, and OPRD conferences. Its customer base spans generic drug manufacturers, innovator pharmaceutical companies, and emerging biotechs requiring specialized peptide or biosynthetic API development.

Teva API firmographics

Firmographics

Name: Teva API
Legal name: Assia Chemical Industries Ltd
Website: https://teva-api.com
Company type: Private
Founded year: 1935
Operating status: Operating
Headcount range: 1,001–5,000 employees
Short description: TAPI is the API manufacturing and CDMO arm of Teva Pharmaceutical Industries, supplying 350+ active pharmaceutical ingredients and custom development services across peptides, oligonucleotides, small molecules, and biosynthetic modalities to global pharmaceutical manufacturers. Founded in 1935 with 1,001–5,000 employees.
Ownership category
akta.pro rank

Teva API industry classification

Industry

Product category: Active Pharmaceutical Ingredients (API) Manufacturing
NAICS: Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical and Medicine Manufacturing (32541)
SIC: Services-Commercial Physical & Biological Research (8731)
akta.pro primary industry: Drug Substance–Drug Product Integrated CDMO (HLAGABAG)
akta.pro secondary industries: Small-Molecule API & Intermediates CDMO (HLAGABAA), Small-Molecule API Commercial Manufacturing (HLAGAHAB), GMP Scale-Up, Tech Transfer & Process Validation (PPQ) (HLAGAHAL), Small-Molecule CMC Documentation & Regulatory Support (DMF/CMC) (HLAGAHAM)

Keywords

Active pharmaceutical ingredients
CDMO services
Generic API manufacturing
Peptide manufacturing
Contract development manufacturing

Where Teva API is headquartered

Location

Headquarters

HQ city: Woodcliff Lake
HQ country: United States
HQ region: North America

Markets served

Teva API business model

Business model

GTM type: B2B
Offering type: Hardware or Manufacturing
Cost components: Operations, Supply Chain, Personnel, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

API Manufacturing and Sales: TAPI manufactures and supplies active pharmaceutical ingredients from its portfolio of 350+ products, serving as the leading international supplier of APIs for generic drug manufacturers worldwide
CDMO Services: Custom development and manufacturing organization services offering tailored solutions across modalities including peptides, oligonucleotides, fermentation products, steroids, small molecules, and high potents/ADC. Revenue generated through development fees, manufacturing fees, and long-term supply agreements
Licensing and Partnership Agreements: Strategic licensing arrangements such as the global license agreement with Sagimet Biosciences for innovative forms of Resmetirom API

Pricing tiers

Model	Billing	Price
Other	Multi-year contract	Quote-based pricing for API products and CDMO services

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Teva API product offering

Product offering

Core offering

TAPI manufactures and supplies active pharmaceutical ingredients (APIs) from a portfolio of over 350 products, serving as the leading international supplier of APIs for generic drug manufacturers worldwide. In addition, TAPI provides custom Contract Development and Manufacturing Organization (CDMO) services across multiple modalities including peptides, oligonucleotides, fermentation products, steroids, small molecules, and high potents/ADC. The company is supported by the TAPI Connect self-service customer portal for document access and order management.

Product overview

TAPI (Technology API Services) is a pharmaceutical Active Pharmaceutical Ingredient (API) manufacturer offering a unified portfolio of over 350 API products combined with CDMO (Contract Development and Manufacturing Organization) services. The core offering consists of the API Catalog for off-the-shelf generic APIs, CDMO Services for custom development and manufacturing, and Peptides & Oligonucleotides for specialized development. TAPI Connect provides the customer-facing digital portal for document access and order management. Founded in 1935, the company leverages 85+ years of manufacturing expertise to serve the global pharmaceutical industry.

Differentiator

Problem solved

Functional benefit

Products and services

API Catalog

Quantifiable outcome

350+ products in portfolio
+1 more outcomes

Companies that use Teva API

Customer profile

Segments4 records

Ideal customer profiles3 records

Teva API technology and API

Technology

Technology focussed No

API detail

Has API: No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Teva API partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

Sagimet BiosciencescoreStrategic or Co-development Partner · 17 December 2025TAPI and Sagimet Biosciences announced a global license agreement for innovative forms of Resmetirom API for Sagimet's fixed dose combination program. TAPI provides licensing for specific API forms supporting Sagimet's pharmaceutical development.
AntheiacoreStrategic or Co-development Partner · 20 November 2025TAPI and Antheia announced a strategic partnership to advance commercialization of biosynthetic pharmaceutical ingredients. This collaboration combines Antheia's biosynthetic technology capabilities with TAPI's manufacturing expertise and global supply chain to bring innovative biosynthetic APIs to market.

Scale indicators3 records

Recent moves5 records

Expansion highlights6 records

Teva API competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Teva API financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Teva API leadership team

Management profile

Number of profiles

Profiles1 record

Teva API funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Teva API M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Teva API

What does Teva API do?

Is Teva API a public or private company?

Teva API is a private company. It is classified as corporate owned and is currently operating.

When was Teva API founded?

Teva API was founded in 1935. It employs 1,001 to 5,000 people.

Where is Teva API based?

Teva API is headquartered in Woodcliff Lake, United States, in the North America region.

How does Teva API make money?

Three revenue lines are on record. API Manufacturing and Sales are the primary driver. The others are CDMO Services and licensing and Partnership Agreements.

Does Teva API have an API?

No public API is recorded for Teva API.

What industry is Teva API in?

Teva API's product category is Active Pharmaceutical Ingredients (API) Manufacturing. Its primary akta.pro industry code is HLAGABAG, Drug Substance–Drug Product Integrated CDMO, with a secondary code of HLAGABAA, Small-Molecule API & Intermediates CDMO. Its NAICS code is 3254 and its SIC code is 8731.